MARC2 Antikörper (C-Term)
Kurzübersicht für MARC2 Antikörper (C-Term) (ABIN453749)
Target
Alle MARC2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Spezifität
- This antibody reacts to MOSC2.
-
Aufreinigung
- Affinity chromatography on Protein A
-
Immunogen
- KLH conjugated synthetic peptide selected from the C-terminal region of human MOSC2
-
-
-
-
Applikationshinweise
-
ELISA: 1/1,000. Western blotting: 1/100 - 1/500.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- MARC2 (Mitochondrial Amidoxime Reducing Component 2 (MARC2))
-
Andere Bezeichnung
- MOSC2
-
Hintergrund
- Catalytic component of the benzamidoxime prodrug-converting complex, a complex required to reduce N-hydroxylated structures, such as benzamidoxime prodrug. Benzamidoxime is an amidine prodrug produced by N-hydroxylation which is used to enhance bioavailability and increase intestinal absorption. It is then reduced into benzamidine, its active amidine, by the benzamidoxime prodrug-converting complex.Synonyms: MOSC domain-containing protein 2, mitochondrial
-
Gen-ID
- 54996
-
NCBI Accession
- NP_060368
-
UniProt
- Q969Z3
Target
-